Inactive Instrument

Press Releases GW Pharmaceuticals plc London S.E.

Equities

GB0030544687

End-of-day quote London S.E. Other stock markets
- ^GBX	-

2021	Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav	RE
2021	Sector Update: Health Care Stocks Steady Premarket Tuesday	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fitch Affirms Jazz's IDR at 'BB-'; Outlook Positive	23-04-06	AQ
Former President of GW Pharmaceuticals USA Joins Lexaria Bioscience as Strategic Advisor	23-01-23	AQ
Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing	22-03-28	AQ
JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS	22-03-02	AQ
Alkame : PAO Group, Inc.'s CBD Nutraceuticals Expected To Deliver Revenue-Generating Catalyst in 2021; New Partnerships Expand Its Long-Term CBD Pharmaceutical Programs	21-05-12	AQ
PAO Group, With A CRO On Its Side, Could Deliver Its First CBD-Based Therapeutic By Year's End	21-05-06	AQ
GW PHARMACEUTICALS PLC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	21-05-05	AQ
GW Pharmaceuticals : Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc	21-05-05	PR
GW PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-05-03	AQ
GW Pharmaceuticals : recognised for leadership in prescription cannabis-based medicines with prestigious Queen's Award for Enterprise in Innovation	21-04-29	AQ
GW Pharmaceuticals : Highest British business award goes to cannabis drug developer, GW Pharmaceuticals	21-04-29	AQ
GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for Enterprise in Innovation	21-04-28	GL
Jazz Pharmaceuticals : GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals	21-04-26	AQ
GW PHARMACEUTICALS PLC : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	21-04-26	AQ
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals	21-04-23	GL
Jazz Pharmaceuticals : PAO Group, Inc. Stock Rockets 28% After Updates Point Toward Near-Term CBD-Based Nutraceutical Commercialization (PAOG)	21-04-23	AQ
Jazz Pharmaceuticals : Announces Proposed Private Offering of Senior Secured Notes	21-04-21	AQ
GW Pharmaceuticals : receives European Commission approval for EPIDYOLEX (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex	21-04-21	AQ
GW PHARMACEUTICALS PLC : Other Events (form 8-K)	21-04-20	AQ
GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex	21-04-20	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases GW Pharmaceuticals plc London S.E.

Equities

GB0030544687

Press Releases

Filters